These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30719901)

  • 21. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification.
    Garrido-Estepa M; León-Gómez I; Herruzo R; Cano R
    Vaccine; 2014 May; 32(22):2604-9. PubMed ID: 24662700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.
    Mattheus W; Hanquet G; Collard JM; Vanhoof R; Bertrand S
    PLoS One; 2015; 10(10):e0139615. PubMed ID: 26425857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination campaign following an increase in incidence of serogroup C meningococcal diseases in the department of Puy-de-Dôme (France).
    Lévy-Bruhl D; Perrocheau A; Mora M; Taha MK; Dromell-Chabrier S; Beytout J; Quatresous I
    Euro Surveill; 2002 May; 7(5):74-6. PubMed ID: 12631934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 26. Statement on meningococcal vaccination for travellers. Committee to Advise on Tropical Medicine and Travel.
    CMAJ; 1995 Aug; 153(3):303-8. PubMed ID: 7614446
    [No Abstract]   [Full Text] [Related]  

  • 27. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.
    Lingappa JR; Rosenstein N; Zell ER; Shutt KA; Schuchat A; Perkins BA;
    Vaccine; 2001 Aug; 19(31):4566-75. PubMed ID: 11483285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal infections in Quebec--1991-92.
    Lavigne P; Boulianne N; Fortin C; Naccache H; Douville-Fradet M
    Can Commun Dis Rep; 1992 Aug; 18(15):113-6. PubMed ID: 1290994
    [No Abstract]   [Full Text] [Related]  

  • 29. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2000 Jun; 49(RR-7):1-10. PubMed ID: 10902834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination.
    Thabuis A; Tararbit K; Taha MK; Dejour-Salamanca D; Ronin V; Parent du Chatelet I; Spaccaferri G
    Euro Surveill; 2018 Jul; 23(28):. PubMed ID: 30017022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine.
    Clarke SC; Edwards GF
    Scott Med J; 2000 Jun; 45(3):67. PubMed ID: 10986736
    [No Abstract]   [Full Text] [Related]  

  • 33. Meningococcal disease in Delhi.
    Taneja A
    Indian Pediatr; 1985 Mar; 22(3):181-4. PubMed ID: 4030053
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
    Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningococcal disease in Newfoundland, 1967-1991.
    Can Commun Dis Rep; 1992 Aug; 18(15):116-7. PubMed ID: 1290995
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine.
    Hellenbrand W; Elias J; Wichmann O; Dehnert M; Frosch M; Vogel U
    J Infect; 2013 Jan; 66(1):48-56. PubMed ID: 23043893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
    Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
    Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.
    De Wals P; Deceuninck G; Boulianne N; De Serres G
    JAMA; 2004 Nov; 292(20):2491-4. PubMed ID: 15562128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.
    Neri A; Pezzotti P; Fazio C; Vacca P; D'Ancona FP; Caporali MG; Stefanelli P
    PLoS One; 2015; 10(10):e0139376. PubMed ID: 26445461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningococcal Disease: Vaccines-Who's at Risk and the Future.
    O'Malley PA
    Clin Nurse Spec; 2018; 32(1):15-18. PubMed ID: 29200035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.